Dow Jones

38,686.32

1.51%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
ETFs
Estados Unidos
AMEX
Invesco Variable Rate Preferred ETF (VRP)
Invesco Variable Rate Preferred ETF (VRP) Noticias

VRP

Invesco Variable Rate Pr... (VRP)

Invesco Variable Rate Preferred ETF

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:VRP

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/02/2021	01:00	GlobeNewswire Inc.	Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
02/02/2021	05:17	GlobeNewswire Inc.	CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD	AMEX:VRP	Invesco Variable Rate Preferred ETF
02/02/2021	01:00	GlobeNewswire Inc.	Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD	AMEX:VRP	Invesco Variable Rate Preferred ETF
14/01/2021	01:00	GlobeNewswire Inc.	Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19	AMEX:VRP	Invesco Variable Rate Preferred ETF
05/01/2021	01:00	GlobeNewswire Inc.	Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference	AMEX:VRP	Invesco Variable Rate Preferred ETF
09/11/2020	01:00	GlobeNewswire Inc.	Verona Pharma Announces November 2020 Virtual Investor Conference Participation	AMEX:VRP	Invesco Variable Rate Preferred ETF
29/10/2020	02:00	GlobeNewswire Inc.	Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020	AMEX:VRP	Invesco Variable Rate Preferred ETF
22/10/2020	01:00	GlobeNewswire Inc.	Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update...	AMEX:VRP	Invesco Variable Rate Preferred ETF
13/10/2020	01:00	GlobeNewswire Inc.	Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020	AMEX:VRP	Invesco Variable Rate Preferred ETF
08/09/2020	01:00	GlobeNewswire Inc.	Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19	AMEX:VRP	Invesco Variable Rate Preferred ETF
02/09/2020	01:00	GlobeNewswire Inc.	Verona Pharma to Present at H.C. Wainwright 22nd Annual Global Virtual Investment Conference	AMEX:VRP	Invesco Variable Rate Preferred ETF
24/08/2020	01:00	GlobeNewswire Inc.	Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2...	AMEX:VRP	Invesco Variable Rate Preferred ETF
19/08/2020	01:00	GlobeNewswire Inc.	Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD	AMEX:VRP	Invesco Variable Rate Preferred ETF
14/08/2020	01:00	GlobeNewswire Inc.	Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020	AMEX:VRP	Invesco Variable Rate Preferred ETF
03/08/2020	01:00	GlobeNewswire Inc.	Verona Pharma Announces August 2020 Virtual Investor Conference Participation	AMEX:VRP	Invesco Variable Rate Preferred ETF
30/07/2020	01:00	GlobeNewswire Inc.	Verona Pharma to Announce Interim Results for the Three and Six Months Ended June 30, 2020 and Provide Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
17/07/2020	01:00	GlobeNewswire Inc.	Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription	AMEX:VRP	Invesco Variable Rate Preferred ETF
14/05/2020	01:00	GlobeNewswire Inc.	Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANC...	AMEX:VRP	Invesco Variable Rate Preferred ETF
01/05/2020	11:12	GlobeNewswire Inc.	Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic...	AMEX:VRP	Invesco Variable Rate Preferred ETF
30/04/2020	01:00	GlobeNewswire Inc.	Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020	AMEX:VRP	Invesco Variable Rate Preferred ETF
23/04/2020	01:00	GlobeNewswire Inc.	Verona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
16/04/2020	06:12	GlobeNewswire Inc.	Verona Pharma plc: Results of AGM	AMEX:VRP	Invesco Variable Rate Preferred ETF
08/04/2020	01:00	GlobeNewswire Inc.	Update on AGM Procedure	AMEX:VRP	Invesco Variable Rate Preferred ETF
31/03/2020	01:00	GlobeNewswire Inc.	Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD	AMEX:VRP	Invesco Variable Rate Preferred ETF
16/03/2020	12:13	GlobeNewswire Inc.	2019 Annual Report and Accounts and Notice of AGM	AMEX:VRP	Invesco Variable Rate Preferred ETF
27/02/2020	01:00	GlobeNewswire Inc.	Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
21/02/2020	01:00	GlobeNewswire Inc.	Verona Pharma plc to Announce Financial Results for Full Year Ended December 31, 2019 and Provide Corporate Update	AMEX:VRP	Invesco Variable Rate Preferred ETF
14/02/2020	01:00	GlobeNewswire Inc.	Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research	AMEX:VRP	Invesco Variable Rate Preferred ETF
03/02/2020	01:00	GlobeNewswire Inc.	Verona Pharma Announces Senior Management Changes	AMEX:VRP	Invesco Variable Rate Preferred ETF
12/01/2020	23:00	GlobeNewswire Inc.	Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium T...	AMEX:VRP	Invesco Variable Rate Preferred ETF